Trials / Active Not Recruiting
Active Not RecruitingNCT05808010
Clinical Study of Umbilical Cord Blood Mononuclear Cell Therapy for the Treatment of Chronic Atrophic Gastritis
- Status
- Active Not Recruiting
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 60 (estimated)
- Sponsor
- Shandong Provincial Hospital · Other Government
- Sex
- All
- Age
- 18 Years – 65 Years
- Healthy volunteers
- Not accepted
Summary
To evaluate the efficacy and safety of umbilical cord blood mononuclear cells in the treatment of chronic atrophic gastritis.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| BIOLOGICAL | Mononuclear cells | 2 times gastric submucosal injection of mononuclear cells (10\^8) at 1 month interval |
| DRUG | Weifuchun+Hydrotalcite/L-Glutamine and Sodium Gualenate Granules | Orally delivered tablets for 7 months. Take it according to the instructions. |
Timeline
- Start date
- 2023-06-07
- Primary completion
- 2025-04-01
- Completion
- 2026-04-01
- First posted
- 2023-04-11
- Last updated
- 2024-04-17
Locations
1 site across 1 country: China
Source: ClinicalTrials.gov record NCT05808010. Inclusion in this directory is not an endorsement.